Tdap vaccination in pregnancy.

Most severe pertussis infections occur in infants

A Canadian study of children (< 17 yr) who were hospitalized for pertusis from 1999–2015 found that infants younger than 2 months had the highest incidence of admission to hospital (116.40, 95% confidence interval [CI] 85.32–147.49 per 100 000 population) and to the intensive care unit (33.48, 95% CI 26.35–40.62 per 100 000 population). All fatal cases of pertussis involved infants aged 3 months and younger.1

Vaccination against tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) in pregnancy has been recommended in Canada since 2018

In 2018, the Canadian National Advisory Committee on Immunization changed their guidance to recommend Tdap vaccination at 27–32 weeks’ gestation in each pregnancy, irrespective of previous immunizations, based on multiple international maternal immunization studies that showed vaccine efficacy.2

Infants receive passive immune protection from maternal Tdap vaccinations during pregnancy

Infants born to mothers immunized with Tdap during pregnancy benefit from transplacental transfer of maternal pertussis antibodies, allowing for immunity in the first months of life, when infants are most at risk of severe pertussis and death.3 A retrospective cohort study involving 148 981 infants found maternal Tdap vaccination was associated with a 91.4% (95% CI 19.5–99.1) reduction in the risk of pertussis among infants in the first 2 months and 69.0% (95% CI 43.6%–82.9%) in the first 12 months of life.4

Tdap vaccination in pregnancy is safe

In 2011, the American College of Obstetricians and Gynecologists began recommending Tdap vaccination during pregnancy. Numerous surveillance studies now support its safety and efficacy. 5 A recent randomized, controlled, observer-blind, multicentre clinical trial showed no difference in rates of maternal–fetal adverse events between patients who received the Tdap vaccine and those who received the tetanus–diphtheria vaccine.6

Cocooning is no longer recommended

Vaccinating family members and close contacts to provide a “cocoon” of protection for the infant is no longer recommended; however, vaccination of individuals who have not previously received the Tdap vaccine is still encouraged.2,5